Analysts expect Alzamend Neuro, Inc. to report revenue of 0.00 for Q1 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q4 25, came in at 0.00.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect Alzamend Neuro, Inc. to report earnings per share of -0.22 for Q2 26, against a range of -0.24 to -0.20. The most recent reported quarter, Q1 26, came in at 0.67, a 226.4% beat against the -0.53 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -3.56 | -1.71 | -2.36 | -1.28 | -0.30 | -0.58 | -0.72 | 0.67 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -3.13 | -3.15 | -2.67 | -1.86 | -0.29 | -0.48 | -0.62 | -0.49 | -0.20 | -0.20 | -0.19 | -0.20 | 0.42 | 0.41 | 0.17 | -0.62 | |||||||||||
| Low Estimate | -3.63 | -3.41 | -2.93 | -2.20 | -0.33 | -0.54 | -0.70 | -0.57 | -0.24 | -0.22 | -0.23 | -0.22 | 0.36 | 0.37 | 0.15 | -0.72 | |||||||||||
| Consensus Estimate | -3.38 | -3.28 | -2.80 | -2.03 | -0.31 | -0.51 | -0.66 | -0.53 | -0.22 | -0.21 | -0.21 | -0.21 | 0.39 | 0.39 | 0.16 | -0.67 |
Pull Wall Street consensus for Alzamend Neuro, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ALZN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ALZN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ALZN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();